NoIR Polarized 22% Amber Spectrashield Medium Frame 44P-36
by NoIR
Last verified June 19, 2026 · classified June 8, 2026
What it is
Summary
AI-generated from vendor-published content · June 8, 2026
These are amber-tinted, polarized sunglasses with wraparound side shields and a top ledge brim — designed to block stray light from above and the sides, not just straight ahead. The 22% light transmission and amber tint reduce glare while improving contrast, which is particularly useful for people with light-sensitive conditions like glaucoma, diabetic retinopathy, or post-cataract surgery recovery. They fit over prescription glasses and provide complete UV protection, making them a practical add-on to existing eyewear rather than a replacement. At this price point they're a low-commitment starting point, but people with complex photosensitivity may benefit from consulting a low-vision specialist to confirm the right tint and transmission level for their specific condition.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
What Setup Looks Like
- Out of the box
- Put them on — wear alone or slip over existing prescription glasses.
- The side shields and top ledge provide immediate glare protection in bright indoor and outdoor environments.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR — view on vendor site; last verified June 19, 2026.
Classification & description AI-generated from vendor-published content on June 8, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.